Botulinum TOX TYP a 1S
Ended Awarded
- Contract number
- SPE2DX25FKVYX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,516
Award facts
- Contract value 100% obligated
- $24,516.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $24,516.21 for Botulinum Toxin Type A (1S) by the Medical Supply Chain, a defense-focused federal agency, with an ultimate completion date of September 24, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies for Department of Defense healthcare facilities nationwide. No set-aside designation was utilized for this award, allowing the contractor to compete on its merits in the federal procurement marketplace.
The delivery order represents a continuation of DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain, providing direct distribution of pharmaceutical products to military health facilities. The contractor's portfolio spans branded and generic prescription drugs, biologics, medical consumables, and specialty medications across multiple therapeutic categories. This specific award for Botulinum Toxin Type A aligns with DMS Pharmaceutical Group's demonstrated capability in delivering specialized pharmaceutical products to federal healthcare systems and reflects the company's consistent performance in supporting Department of Defense medical supply requirements.
Quick answers
Who was awarded contract SPE2DX25FKVYX?
SPE2DX25FKVYX was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2DX25FKVYX worth?
The government has obligated $24,516 on SPE2DX25FKVYX.
Is contract SPE2DX25FKVYX an order under another contract?
Yes. SPE2DX25FKVYX is a delivery order under SPE2DX15D9628, an indefinite delivery contract.
Was contract SPE2DX25FKVYX competed?
The extent of competition for SPE2DX25FKVYX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award